# Cognitive Enhancement Therapy for Early-Stage Schizophrenia

> **NCT00167362** · PHASE3 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 67 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **BEHAVIORAL:** Cognitive enhancement therapy (CET)
- **BEHAVIORAL:** Enriched supportive therapy (EST)

## Key facts

- **NCT ID:** NCT00167362
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2009-08
- **Final completion:** 2016-12
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2017-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00167362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00167362, "Cognitive Enhancement Therapy for Early-Stage Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00167362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*